Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Comparison of FTIR Spectra in AMD – V 2.0

Posted on By

Analytical Method Development: Comparison of FTIR Spectra in AMD – V 2.0

SOP for Comparative Evaluation of FTIR Spectra in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/100/2025
Supersedes SOP/AMD/100/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the methodology for performing comparative evaluation of FTIR spectra generated during Analytical Method Development (AMD). The objective is to determine the degree

of spectral similarity between test samples, reference standards, and placebos to support identity, conformity, or specificity conclusions.

2. Scope

This SOP applies to all FTIR analyses conducted using KBr pellet or ATR techniques in the AMD laboratory for Active Pharmaceutical Ingredients (APIs), excipients, intermediates, and formulations. It covers spectrum comparison, overlay assessment, and reporting requirements.

3. Responsibilities

  • Analytical Chemist: Prepares and scans samples, performs spectrum overlays, and documents comparison outputs.
  • Reviewer: Verifies match percentages, peak alignments, and interprets deviations.
  • QA Officer: Reviews documentation and ensures regulatory compliance.
  • Head – AMD: Approves final interpretation and method development conclusions based on comparison data.
See also  Analytical Method Development: Stability-Indicating Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the integrity of FTIR spectral comparisons and their scientific justification within development reports and validation documents.

5. Procedure

5.1 Sample and Reference Preparation

  1. Prepare test sample, reference standard, and placebo (if applicable) using the approved FTIR method (ATR or KBr pellet).
  2. Ensure all samples are dried appropriately and prepared under similar environmental conditions.
  3. Label all spectra with unique identifiers, date, analyst initials, and method used.
  4. Document in Annexure-1: Sample Preparation Log.

5.2 FTIR Scanning Parameters

  1. Set instrument parameters uniformly for all spectra being compared:
    • Scan range: 4000–400 cm-1
    • Resolution: 4 cm-1
    • Number of scans: 32–64
  2. Perform background correction before each sample scan.
  3. Export spectra in compatible formats (e.g., ASCII, .spc) for overlay comparison.
  4. Document scan parameters in Annexure-2: Scan Settings Log.

5.3 Spectral Overlay and Match Assessment

  1. Use FTIR software (e.g., OMNIC, Spectrum, or instrument manufacturer software) to overlay test and reference spectra.
  2. Align spectra at a common baseline and adjust scaling if necessary (without distorting original values).
  3. Focus on fingerprint region (1800–600 cm-1) for match analysis.
  4. Key match parameters:
    • Peak positions within ±5 cm-1
    • Peak intensities within ±10%
    • Absence of additional peaks in test spectrum
  5. Record visual overlay and software-calculated match percentage (target ≥ 95%).
  6. Document in Annexure-3: Overlay Evaluation Sheet.
See also  Analytical Method Development: SOP for Stability-Indicating Method Development - V 2.0

5.4 Fingerprint Region Comparison

  1. Assign functional groups to key peaks based on known IR absorption ranges.
  2. Compare the number, position, and sharpness of peaks between test and reference.
  3. Note any peak shifts or missing peaks and investigate possible causes (e.g., polymorphism, moisture, processing).
  4. Capture observations in Annexure-4: Fingerprint Interpretation Sheet.

5.5 Reporting and Conclusion

  1. Summarize comparison findings:
    • Overlay match percentage
    • Key spectral differences (if any)
    • Confirmation of identity or deviation reason
  2. If results support conformity, the FTIR spectrum may be included in the analytical method or COA specification.
  3. Record final remarks and reviewer approval in Annexure-5: Comparison Summary.

6. Abbreviations

  • FTIR: Fourier Transform Infrared
  • ATR: Attenuated Total Reflectance
  • KBr: Potassium Bromide
  • API: Active Pharmaceutical Ingredient
  • cm-1: Wavenumber
  • SOP: Standard Operating Procedure

7. Documents

  1. Sample Preparation Log – Annexure-1
  2. Scan Settings Log – Annexure-2
  3. Overlay Evaluation Sheet – Annexure-3
  4. Fingerprint Interpretation Sheet – Annexure-4
  5. Comparison Summary – Annexure-5
See also  Analytical Method Development: SOP for Raman Spectroscopy Method Development - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <197K> – FTIR Spectroscopy Identification
  • Instrument Manufacturer Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Preparation Log

Sample ID Material Method Used Operator Date
FTIR-100-01 Ibuprofen ATR Rajesh Kumar 19/05/2025

Annexure-2: Scan Settings Log

Scan Range Resolution No. of Scans Mode Background Done
4000–400 cm-1 4 cm-1 64 Absorbance Yes

Annexure-3: Overlay Evaluation Sheet

Test vs Reference Match % Baseline Aligned Conclusion
FTIR-100-01 vs REF-IBU 97.2% Yes Acceptable

Annexure-4: Fingerprint Interpretation Sheet

Wavenumber (cm-1) Functional Group Test Peak Reference Peak Status
1710 C=O Stretch 1710 1709 Match
2955 CH Stretch 2955 2956 Match

Annexure-5: Comparison Summary

Analyst Observation Conclusion Reviewed By
Sunita Reddy Spectrum matched with minor baseline shift Confirmed QA Officer

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added overlay match criteria and expanded fingerprint assessment annexures Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Handling Deviations and Incident Reports – V 2.0
Next Post: Creams: SOP for Monitoring Cream Appearance during Production – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version